Published in Vaccine Weekly, June 4th, 2008
Replikins appear to be possible agents or promoters of infectivity, host morbidity and mortality. Timely repeated analyses of cyclic changes in an organism's replikin structure may be useful to bring current the targets for the chemical synthesis of ReplikinBestFit(TM) vaccines. These strain-specific...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly